WENZHOU, ZHEJIANG PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- As the global pharmaceutical and healthcare ...
Halo Pharma's transition to a standalone CDMO allows a concentrated focus on drug product services, enhancing technical ...
“The global API manufacturing market is going through some major changes these days,” says Sean O’Brien, COO, Abzena. He ...
BioSelective Capital Investments and Shayan Enterprises, LLC, a Utah-based risk-capital investment firm, today announced the successful acquisition of BioDuro's drug product development and ...
In the final days of 2025, Vietnam’s pharmaceutical sector marked a significant milestone as Imexpharm Corporation introduced ...
Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal ...
Sales of $386 million, down five percent from the prior-year quarterPreviously announced Avoca divestiture reduced overall ...
Regulatory News: Hoffmann Green Cement Technologies (ISIN: FR0013451044, Ticker: ALHGR) ("Hoffmann Green Cement" or the "Company"), an industrial player committed to the decarbonation of the ...
Good morning and good afternoon, and welcome to the Novartis Q4 Full Year 2025 Results Release Conference Call and Live ...
Oncoinvent, a clinical stage, radiopharmaceutical company developing innovative treatments for solid cancers, today announces that the first patient has been enrolled at one of the newly activated ...
President Donald Trump named former Fed Governor Kevin Warsh his replacement pick to take over the U.S. central bank.
Phase 2 Data Strengthened, Strong Cash Position, and Phase 3 Planning Well Advanced −Highlights Phase 2 data for ATH434 in Multiple System ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results